CardioDx Announces Medicare Coverage for Corus CAD Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease
07:00 EDT 8 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
CardioDx, Inc., a pioneer in the field of cardiovascular genomic
diagnostics, today announced that Palmetto GBA, a national contractor
that administers Medicare benefits, has established coverage for the
company’s Corus® CAD ...
Other Sources for this Article
For CardioDx
Nicole Osmer, 650-454-0504
nicole@nicoleosmer.com
More From BioPortfolio on "CardioDx Announces Medicare Coverage for Corus CAD Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
